You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 1, JANUARY 1964 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (8)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Bilharzial Splenomegaly

Z. FARID, MD; A. S. PRASAD, MD, PhD; A. R. SCHULERT, PhD; H. H. SANSTEAD, MD; ABOU SHADI EL ROOBY, MD

Arch Intern Med. 1964;113(1):37-41.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Bilharzial hepatic fibrosis, usually accompanied by marked enlargement of the spleen, leukopenia, thrombocytopenia, and hypochromic anemia, is endemic in Egypt.1 The possibility that the enlarged bilharzial spleen may acquire hypersplenic activity and cause hemolytic anemia has been discussed by workers from Egypt2 and elsewhere3; however, no convincing evidence to prove this has been reported in the literature. Recently, Jandl et al4 have described a method for determining the sites of red cell destruction by using Cr51. We have used this technique to study the Cr51 red cell half-survival time and the uptake of radioactivity by the spleen, liver, and precordium in four patients with proved bilharzial hepatosplenomegaly. In addition, other hematological and biochemical tests were carried out. In none of these patients did we produce evidence of anemia due to hypersplenism.

Methods and Materials

Four patients with marked hepatosplenomegaly were studied. Liver biopsy, performed . . . [Full Text PDF of this Article]


Author Affiliations

CAIRO, EGYPT, AND NASHVILLE, TENN

From the Medical Department, United States Naval Medical Research Unit No. 3, and Kasr El Aini Faculty of Medicine, Cairo University, Cairo, Egypt, UAR, and departments of biochemistry and medicine, Vanderbilt University School of Medicine, Nashville, Tenn.


Footnotes

Received for publication Feb 13, 1963; accepted March 4.

The opinions and assertions contained herein are the private ones of the authors and are not to be construed as official or reflecting the views of the Navy Department, the naval service at large, or the Egyptian Ministry of Public Health.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1964 American Medical Association. All Rights Reserved.